Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.20
-0.21 (-1.08%)
Aug 14, 2025, 11:25 AM - Market open
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$455,018
Profits / Employee
-$12,439
Market Cap
556.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CSTL News
- 9 days ago - Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Castle Biosciences Reports Second Quarter 2025 Results - GlobeNewsWire
- 16 days ago - Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 20 days ago - Castle Biosciences' Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal - GlobeNewsWire
- 22 days ago - FDA Grants Breakthrough Device Designation to Castle Biosciences' DecisionDx®-Melanoma Test - GlobeNewsWire
- 4 weeks ago - Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company's Strong Culture - GlobeNewsWire
- 4 weeks ago - Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025 - GlobeNewsWire
- 2 months ago - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire